Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Beng Hooi Phang"'
Monoclonal Antibodies against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine
Autor:
Le-Ann Hwang, Beng Hooi Phang, Oi Wah Liew, Jabed Iqbal, Xiao Hui Koh, Xin Yu Koh, Rashidah Othman, Yuezhen Xue, A. Mark Richards, David P. Lane, Kanaga Sabapathy
Publikováno v:
Cell Reports, Vol 36, Iss 6, Pp 109498- (2021)
Externí odkaz:
https://doaj.org/article/f266ff945e92477783e50248e2c7ba7a
Monoclonal Antibodies against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine
Autor:
Le-Ann Hwang, Beng Hooi Phang, Oi Wah Liew, Jabed Iqbal, Xiao Hui Koh, Xin Yu Koh, Rashidah Othman, Yuezhen Xue, A. Mark Richards, David P. Lane, Kanaga Sabapathy
Publikováno v:
Cell Reports, Vol 22, Iss 1, Pp 299-312 (2018)
Summary: The large number of mutations identified across all cancers represents an untapped reservoir of targets that can be useful for therapeutic targeting if highly selective, mutation-specific reagents are available. We report here our attempt to
Externí odkaz:
https://doaj.org/article/f1c84eea464845cc98ed94b45e71f1c7
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e15320 (2011)
Multiple single nucleotide polymorphisms (SNPs) have been identified in the tumor suppressor gene p53, though the relevance of many of them is unclear. Some of them are also differentially distributed in various ethnic populations, suggesting selecti
Externí odkaz:
https://doaj.org/article/176d681387e5477d9c37a364d0e5f10c
Autor:
Shen Kiat Lim, Chen Chen Peng, Shannon Low, Varsheni Vijay, Andrea Budiman, Beng Hooi Phang, Jing Quan Lim, Anand D. Jeyasekharan, Soon Thye Lim, Choon Kiat Ong, Suet-Mien Tan, Yinghui Li
Publikováno v:
Leukemia. 37:441-452
DLBCL is the most common lymphoma with high tumor heterogeneity. Treatment refractoriness and relapse from R-CHOP therapy in patients remain a clinical problem. Activation of the non-canonical NF-κB pathway is associated with R-CHOP resistance. Howe
Monoclonal Antibodies against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine
Autor:
Rashidah Othman, Jabed Iqbal, Xin Yu Koh, A. Mark Richards, Kanaga Sabapathy, Le-Ann Hwang, Xiao Hui Koh, Yuezhen Xue, David P. Lane, Beng Hooi Phang, Oi Wah Liew
Publikováno v:
Cell Reports, Vol 22, Iss 1, Pp 299-312 (2018)
Cell Reports, Vol 36, Iss 6, Pp 109498-(2021)
Cell Reports, Vol 36, Iss 6, Pp 109498-(2021)
Summary: The large number of mutations identified across all cancers represents an untapped reservoir of targets that can be useful for therapeutic targeting if highly selective, mutation-specific reagents are available. We report here our attempt to
Publikováno v:
Cancer Cell. 22:751-764
SummaryThe specific roles of mutant p53's dominant-negative (DN) or gain-of-function (GOF) properties in regulating acute response and long-term tumorigenesis is unclear. Using “knockin” mouse strains expressing varying R246S mutant levels, we sh
Autor:
Venkatesh Gopalan, Rashidah Othman, Han Chong Toh, Who Whong Wang, Sanjay Kumar Verma, Kanaga Sabapathy, S. Sendhil Velan, Wei Wei Teoh, Beng Hooi Phang, Jadegoud Yaligar, Swee Shean Lee
Publikováno v:
Scientific Reports
The cumulative effects of hepatic injury due to hepatitis B virus (HBV) infections and aflatoxin-B1 (AFB1) exposure are the major risk factors of HCC. Understanding early metabolic changes involving these risk factors in an animal model closely resem
Publikováno v:
European Journal of Cancer. 44:760-766
Although mutations in p53 are rare in leukaemia, MDM2, the negative regulator of p53, is often overexpressed. Recently, a single nucleotide polymorphism (SNP) in the MDM2 promoter - within the oestrogen-receptor-binding region - resulting in either a
Autor:
Gaëlle Bougeard, Ren Hui Chia, Peh Yean Cheah, Kanaga Sabapathy, Choong Leong Tang, Beng Hooi Phang, Rashidah Othman, Thierry Frebourg
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2015, 112 (46), pp.E6349-E6358. ⟨10.1073/pnas.1510043112⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2015, 112 (46), pp.E6349-E6358. ⟨10.1073/pnas.1510043112⟩
Whereas most mutations in p53 occur in the DNA-binding domain and lead to its functional inactivation, their relevance in the amino-terminal transactivation domain is unclear. We show here that amino-terminal p53 (ATp53) mutations often result in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::507304d7272ab6e98a6f677663eed494
https://hal-normandie-univ.archives-ouvertes.fr/hal-02356393
https://hal-normandie-univ.archives-ouvertes.fr/hal-02356393
Publikováno v:
Cancer. 89:811-816
BACKGROUND In recent years, although BRCA1 has been extensively investigated, the contribution of inherited BRCA1 mutations to breast carcinoma in Asian populations is largely unknown. The authors undertook this study to determine the prevalence and